Individuals with Metabolic Syndrome Show Altered Fecal Lipidomic Profiles with No Signs of Intestinal Inflammation or Increased Intestinal Permeability

Background: Metabolic Syndrome (MetS) is a clinical diagnosis where patients exhibit three out of the five risk factors: hypertriglyceridemia, low high-density lipoprotein (HDL) cholesterol, hyperglycemia, elevated blood pressure, or increased abdominal obesity. MetS arises due to dysregulated metab...

Descripción completa

Detalles Bibliográficos
Autores principales: Coleman, Mia J., Espino, Luis M., Lebensohn, Hernan, Zimkute, Marija V., Yaghooti, Negar, Ling, Christina L., Gross, Jessica M., Listwan, Natalia, Cano, Sandra, Garcia, Vanessa, Lovato, Debbie M., Tigert, Susan L., Jones, Drew R., Gullapalli, Rama R., Rakov, Neal E., Torrazza Perez, Euriko G., Castillo, Eliseo F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143200/
https://www.ncbi.nlm.nih.gov/pubmed/35629938
http://dx.doi.org/10.3390/metabo12050431

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143200/
https://www.ncbi.nlm.nih.gov/pubmed/35629938
http://dx.doi.org/10.3390/metabo12050431

Ejemplares similares